Alprostadil Injection

DRUG2 trials

Sponsors

Guangzhou Yipinhong Pharmaceutical CO.,LTD, The Affiliated Hospital of Xuzhou Medical University

Conditions

Arteriosclerosis ObliteransChronic Renal Disease

Phase 2

A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans

Guangzhou Yipinhong Pharmaceutical CO.,LTDArteriosclerosis Obliterans

Start: 2016-08-31End: 2017-12-31Target: 160Updated: 2017-03-10

Phase 4

Evaluation of Nail Fold Microcirculation in CKD

The Affiliated Hospital of Xuzhou Medical UniversityChronic Renal Disease

Start: 2018-02-01End: 2019-04-30Target: 100Updated: 2018-09-26